Skip to main content
. 2015 Mar 16;106(5):592–597. doi: 10.1111/cas.12638

Fig 2.

Fig 2

Kaplan–Meier curves showing recurrence-free survival and overall survival based on the Interleukin (IL)-11 expression levels in (a, b) all patients, (c, d) TNM stage I + II, and (e, f) stage III + IV patients with clear-cell renal cell carcinoma.